Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 381,807
  • Shares Outstanding, K 132,572
  • Annual Sales, $ 433,140 K
  • Annual Income, $ 4,950 K
  • 60-Month Beta 1.65
  • Price/Sales 0.89
  • Price/Cash Flow 13.49
  • Price/Book 1.46
Trade ORGO with:

Options Overview Details

View History
  • Implied Volatility 61.15% ( -40.58%)
  • Historical Volatility 67.38%
  • IV Percentile 10%
  • IV Rank 10.70%
  • IV High 277.31% on 04/03/24
  • IV Low 35.24% on 10/09/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 7
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 2.69
  • Today's Open Interest 856
  • Open Int (30-Day) 838

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.28 +26.32%
on 08/12/24
3.13 -7.99%
on 07/31/24
-0.14 (-4.64%)
since 07/30/24
3-Month
2.28 +26.32%
on 08/12/24
3.28 -12.06%
on 07/25/24
+0.15 (+5.49%)
since 05/30/24
52-Week
1.96 +46.94%
on 11/09/23
4.70 -38.79%
on 01/08/24
+0.08 (+2.86%)
since 08/29/23

Most Recent Stories

More News
Organogenesis (ORGO) Q2 2024 Earnings Call Transcript

ORGO earnings call for the period ending June 30, 2024.

ORGO : 2.88 (-0.69%)
Organogenesis: Q2 Earnings Snapshot

Organogenesis: Q2 Earnings Snapshot

ORGO : 2.88 (-0.69%)
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript

ORGO earnings call for the period ending March 31, 2024.

ORGO : 2.88 (-0.69%)
Why Organogenesis Holding Stock Plummeted by 18% Today

A double miss put the wound care specialist's shares on the sick list.

ORGO : 2.88 (-0.69%)
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript

ORGO earnings call for the period ending December 31, 2023.

ORGO : 2.88 (-0.69%)
Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

ORGO earnings call for the period ending September 30, 2023.

ORGO : 2.88 (-0.69%)
Why Shares of Organogenesis Holdings Are Up Thursday

The company said it learned that its products will again be covered by three Medicare Administrative Contractors.

ORGO : 2.88 (-0.69%)
Why Shares of Organogenesis Holdings Are Dropping Thursday

The advanced wound care company announced second-quarter earnings.

ORGO : 2.88 (-0.69%)
Organogenesis (ORGO) Q2 2023 Earnings Call Transcript

ORGO earnings call for the period ending June 30, 2023.

ORGO : 2.88 (-0.69%)
Why Shares of Organogenesis Climbed Wednesday

A competitor's recall could help the advanced wound care company gain market share.

ORGO : 2.88 (-0.69%)

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 2.97
2nd Resistance Point 2.94
1st Resistance Point 2.91
Last Price 2.88
1st Support Level 2.85
2nd Support Level 2.82
3rd Support Level 2.79

See More

52-Week High 4.70
Fibonacci 61.8% 3.66
Fibonacci 50% 3.33
Fibonacci 38.2% 3.01
Last Price 2.88
52-Week Low 1.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar